Oncimmune, a global leader in biomarker services is focused on antibody (autoantibody) biomarker profiling in immuno-oncology, autoimmune and infectious diseases. Through its ImmunoINSIGHTS™ technology platform, the company provides insights to discover and validate novel biomarkers, improve treatment responses and adverse event (irAE) prediction, patient screening and diagnostic accuracy.
Oncimmune is headquartered in the UK with operations in Germany, UK and USA.
Site |
Badges |
|
Oncimmune Holdings PLC
Otto-Hahn-Str. 15
Dortmund, , 44227
Germany
|
|
|
Oncimmune LLC
One Broadway, 14th Floor
Cambridge, , MA, 02142
United States
|
|
|
Oncimmune Germany GmbH
Otto-Hahn-Str. 15
Dortmund, , 44227
Germany
|
|